Trials / Completed
CompletedNCT03685539
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
Advanced CT Imaging Optimization for the Detection of Intracranial Metastasis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies how well dual energy computed tomography (DECT) works in imaging patients with solid organ cancer that has spread to the brain. Imaging techniques, such as DECT, may help find and diagnose tumor cells and find out how far the tumor cells have spread in the brain.
Detailed description
PRIMARY OBJECTIVES: I. To optimize two major parameters of computed tomography (CT) imaging for optimal detection of intracranial metastatic lesions. Ia. Virtual monochromatic image reconstruction. Ib. Contrast bolus timing. II. To measure the detection accuracy of CT compared to the diagnostic standard of care gadolinium-based "Gamma Knife (GK)" protocol magnetic resonance imaging (MRI). OUTLINE: Within 7 days before the standard Gamma Knife MRI, patients undergo DECT scan over 6 seconds at 1.5, 5, 10, and 20 minutes after receiving the contrast agent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dual-Energy Computed Tomography | Undergo DECT |
Timeline
- Start date
- 2018-08-24
- Primary completion
- 2023-08-29
- Completion
- 2023-08-29
- First posted
- 2018-09-26
- Last updated
- 2023-08-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03685539. Inclusion in this directory is not an endorsement.